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Abstract: The aim of the study was to characterize the chemical composition and biological
properties of the essential oil from the plant Lippia citriodora grown in Greece. The essential
oil volatiles were analyzed by gas chromatography–mass spectrometry GC-MS indicating citral
as the major component. The antimicrobial properties were assayed using the disk diffusion
method and the minimum inhibitory and non-inhibitory concentration values were determined.
Listeria monocytogenes, Staphylococcus epidermidis, Staphylococcus aureus, Saccharomyces cerevisiae,
and Aspergillus niger were sensitive to Lippia citriodora oil, but not Escherichia coli, Salmonella Enteritidis,
Salmonella typhimurium, and Pseudomonas fragi. Adversely, all microbes tested were sensitive to citral.
2,2-Diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid)
(ABTS) assays were used to assess direct antioxidant activity, which proved to be weak for both
agents, while comet assay was utilized to study the cytoprotective effects against H2O2-induced
oxidative damage in Jurkat cells. Interestingly, the oil showed a more profound cytoprotective
effect compared to citral. The antiproliferative activity was evaluated in a panel of cancer cell lines
using the sulforhodamine B (SRB) and 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-S-(phenylamino)
carbonyl-2-tetrazolium hydroxide (XTT) assays and both agents demonstrated potent antiproliferative
activity with citral being more cytotoxic than the oil. Taken together, the essential oil of Lippia citriodora
and its major component, citral, exert diverse biological properties worthy of further investigation.
Keywords: Lippia citriodora; citral; composition; antimicrobial; antioxidant; antiproliferative
1. Introduction
Nowadays, public interest for natural products has increased; thus research has focused on
exploring their activities as therapeutic agents for a broad range of pathological conditions including
various types of cancer. Phytochemicals have been shown to reduce cancer cell viability and migration
and interfere with intracellular pathways by altering the expression profiles of many genes [1–3].
Based on the promising biological properties that many compounds possess and their few side-effects,
dietary natural products have attained a significant interest in being used as protective and therapeutic
Molecules 2018, 23, 123; doi:10.3390/molecules23010123 www.mdpi.com/journal/molecules
Molecules 2018, 23, 123 2 of 13
agents against cancer. In addition, there is also a growing trend in discovering new compounds of
natural origin as food preservatives with many of them possessing such potential [4]. Thus, there is an
ever-increasing trend in identifying novel natural compounds with biological significance for their
exploitation both in the pharmaceutical and food industries.
Lippia citriodora, commonly known as lemon verbena, belongs to the Lippia genus, which contains
around 200 species. It was originally cultivated in South and Central America and was brought to
Europe in the 17th century [5]. There are published data on the activities of different extracts of the plant
prepared by infusion or decoction [6–8]. Its leaves are mainly used for the preparation of infusions
which have been utilized for the relief of gastrointestinal symptoms. In addition, antispasmodic,
diuretic, and sedative properties have also been described; however, the literature is sparse regarding
the biological activities of the essential oil extracted from the plant.
Therefore, the aim of this study was to identify the composition of the essential oil of Lippia
citriodora isolated from Greek plants and characterize its biological activities. We report here the
(i) antimicrobial; (ii) antioxidant; (iii) cytoprotective (against H2O2-induced oxidative damage),
and (iv) antiproliferative properties associated with the essential oil fraction derived from the leaves
and stems of the plant. Finally, its major component, citral, was also evaluated for its biological
properties in vitro and compared to the essential oil. To our knowledge, this is the first detailed study
on distinct biological properties of the essential oil fraction of Lippia citriodora.
2. Results and Discussion
2.1. Chemical Composition
A total of 43 compounds, representing 87% of the total chromatographic area, were identified
(Table 1). Neral (cis-citral) and geranial (trans-citral) reported as citral (which is the sum of the
two isomers) accounted for 17.2% and 26.4%, respectively. Other major compounds identified were
nerol (8.0%), geraniol (5.7%), spathulenol (3.3%), 1.8 cineol (3.2%) and limonene (2.2%). The results of
the present study are in accordance with existing literature as geranial is reported as one of the main
components of Citriodora species essential oil [9].
Table 1. Volatiles identified in the essential oil of Lippia citriodora and their relative percent (%) area.
KRI* Compounds % Area
795 trans-hex-2-enal 0.024
805 cis-hex-3-enol 0.084
819 trans-hex-2-enol 0.013
920 α-pinene 0.041
946 oct-1-en-3-one 0.072
954 6-methyl-hept-5-en-2-noe 2.278
956 oct-1-en-3-ol 1.434
971 octan-3-ol 0.079
972 myrcene 0.100
978 cis-hex-3-enyl acetate 0.071
1008 1,8-cineol 3.150
1010 limonene 2.166
1019 cis-b-ocimene trace
1030 trans-b-ocimene 0.386
1043 sabinenehydrate 0.267
1077 nonanal 0.053
1080 linalol 0.396
1137 cis-isocitral 0.485
1165 a-terpineol 1.119
1212 nerol 8.047
1215 cis-citral 17.160
1219 piperitone 0.193
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Table 1. Cont.
KRI* Compounds % Area
1241 geraniol 5.720
1246 trans-citral 26.404
1278 thymol or carvacrol 0.462
1324 eugenol 0.190
1340 geranic acid 0.195
1360 geranyl acetate 0.999
1366 a-copaene 0.263
1367 methyl eugenol 0.129
1373 b-bourbonene 0.199
1400 a-cedrene 0.283
1405 caryophyllene 1.439
1462 d-germacrene 1.150
1464 ar-curcumene 2.098
1479 zingiberene 0.536
1479 bicyclogermacrene 1.750
1504 cubenol A 0.215
1543 nerolidol 0.753
1551 spathulenol 3.279
1554 caryophyllene oxide 1.375
1607 iso-spathulenol 0.452
1611 T-cadinol 0.558
KRI*: Kovats Retention Indices.
2.2. Antimicrobial Activitys
The antimicrobial activity of Lippia citriodora essential oil and its main constituent was evaluated
against seven common food spoilage and pathogenic bacteria, as well as against S. cerevisiae and
A. niger, which have been used previously as model systems in food spoilage.
Initially, the disk diffusion method was applied and subsequently the minimum inhibitory
concentration (MIC) and non-inhibitory concentration (NIC) values were assessed using an established
optical density method, which combines the absorbance measurements with the common dilution
method. Non-linear regression analysis was used to fit the data using a previously-published
model [10,11]. The data indicated that only S. epidermidis, S. aureus, and L. monocytogenes were
sensitive to Lippia citriodora essential oil, although all bacteria were sensitive to citral (Table 2). Of note,
large inhibition zones were observed in both S. cerevisiae uvaferm NEM (Table 2) and A. niger 19111
for both agents (inhibition zone of 20 ± 0.5 mm for 100 spores/plate initial inoculum) (the inhibition
zones disappeared after one day of incubation), which were similar to the positive control [12].
Table 2. Antimicrobial activity of the Lippia citriodora essential oil against common food spoilage and
pathogenic microbes monitored by the disk diffusion assay.
Lippia citriodora Essential Oil Citral
Initial Inoculum
Microbial Species 5 log cfu/mL 7 log cfu/mL 5 log cfu/mL 7 log cfu/mL
Salmonella Enteritidis 0 0 10 ± 0.5 7 ± 0.3
Salmonella typhimurium 0 0 10 ± 0.3 8 ± 0.5
Escherichia coli 0 0 11 ± 0.7 7 ± 0.5
Listeria monocytogenes 12 ± 0.7 10 ± 0.3 20 ± 0.3 15 ± 0.5
Staphylococcus epidermidis 20 ± 0.25 16 ± 0.3 25 ± 0.5 19 ± 0.3
Staphylococcus aureus 13 ± 0.5 11 ± 0.7 23 ± 0.5 19 ± 0.3
Pseudomonas fragi 0 0 10 ± 0.5 7 ± 0.3
Saccharomyces cerevisiae 20 ± 0.5 12 ± 0.7 25 ± 0.7 18 ± 0.3
The inhibition zones were measured in mm.
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In accordance with the results of the disc diffusion method, MIC and NIC determination
documented the effective growth inhibition of Lippia citriodora essential oil against S. epidermidis,
S. aureus, and L. monocytogenes and citral against all bacteria tested (Table 3), although MIC and NIC
values were significantly (p < 0.05) higher compared to ciproxin, which was used as positive control [12].
Noticeably, the oil was more effective compared to citral, as significantly (p < 0.05) lower MIC and
NIC values were recorded. Similar results reporting high antimicrobial activity of Lippia citriodora
essential oil and extracts were previously reported [6,13,14]. However, they were only limited to disc
or well diffusion assays and no MIC and NIC values were determined. The antimicrobial activity of
the essential oil could be attributed to the action of its main constituent, although possible antagonistic
effects should not be excluded [15,16]. Such effects must be further studied using model systems.
Table 3. MIC and NIC (µg/mL) of Lippia citriodora essential oil and citral against common food spoilage
and pathogenic bacteria. Ciproxin was used as control.
Lippia Citriodora
Essential Oil Citral *
Ciproxin (Data Reproduced
by Fitsiou et al. [12])
Microbial species MIC NIC MIC NIC MIC NIC
Salmonella Enteritidis - - 7051 ± 26 6393 ± 18 0.976 ± 0.001 0.957 ± 0.001
Salmonella typhimurium - - 7603 ± 26 6121 ± 9 0.979 ± 0.001 0.964 ± 0.001
Escherichia coli - - 7024 ± 9 6340 ± 18 0.984 ± 0.001 0.956 ± 0.002
Listeria monocytogenes 1794 ± 9 179 ± 9 6919 ± 18 4981 ± 18 0.979 ± 0.001 0.968 ± 0.001
Staphylococcus epidermidis 1758 ± 11 538 ± 19 6954 ± 18 5779 ± 9 0.979 ± 0.002 0.957 ± 0.002
Staphylococcus aureus 923 ± 19 98 ± 9 6901 ± 18 4972 ± 9 0.982 ± 0.002 0.963 ± 0.003
Pseudomonas fragi - - 7112 ± 27 5235 ± 9 0.955 ± 0.001 0.940 ± 0.002
* Mixture of 40% cis- and 60% trans-citral.
2.3. Antioxidant Activity
In the present study, the DPPH and ABTS assays were used for the evaluation of the antioxidant
capacity of the oil and citral. More particularly, increasing concentrations of the essential oil
(0.0046–46 mg/mL) and citral (0.0045–45 mg/mL) were incubated with DPPH and ABTS for 30 and
15 min, respectively. The IC50 values for the essential oil were 6.3 ± 0.25 mg/mL for the DPPH assay
and 3.08± 0.3 mg/mL using the ABTS method. Citral did not show any significant antioxidant activity
(maximum DPPH inhibition 3.9% and ABTS inhibition 22.45%; Table 4).
Table 4. Antioxidant activity of the essential oil of Lippia citriodora and citral using the DPPH and
ABTS assays.
DPPH ABTS
IC50 (mg/mL) IC50 (mg/mL) (µmolesEA/g) *
Lippia citriodora oil 6.3 ± 0.25 3.08 ± 0.3 3115.2
Citral n.d. n.d. 773.7
Ascorbic acid 0.0054 ± 0.00035 0.0054 ± 0.00041 -
Data are presented as Mean ± SD of at least three independent experiments, * micromoles ascorbic acid equivalent
per gram of essential oil. Ascorbic acid was used as a positive control. n.d. = not determined.
The radical scavenging activity of citral has been tested before using the DPPH and ABTS assays,
showing significant activity (IC50 values ranging from 30 to 260 µg/mL), in disagreement with our
results [17–19]. Compared to lemon verbena oil, its activity was weaker showing that the oil probably
owes its radical scavenging activity to its other constituents, as this is the case for other oils as well [20].
Both assays showed the same trend, however, in the ABTS method, both agents demonstrated a more
potent antioxidant potential. Regardless of the assays used, their activity was shown to be less when
compared to the potent antioxidant, ascorbic acid (Table 4). Differences in the results from the two
assays have been reported before, where extracts were found to be more effective as ABTS rather
than DPPH scavengers [21,22]. These differences can be attributed to a variety of factors, such as
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stereoselectivity of the radicals, solubility of the extracts in the different systems, and underlying
mechanism(s) of action of the reaction [23,24].
2.4. Genotoxic or Cytoprotective (Against H2O2-Induced Oxidative Damage) Activity
The genotoxic effects of the oil fraction or citral were investigated using the comet assay.
We observed that the oil fraction demonstrated a genotoxic effect only at the highest concentration
used (920 µg/mL) in Jurkat cells after 20 min of incubation, which was approximately one and a half
times the levels of DNA damage of the control sample (Figure 1A). Conversely, citral exhibited a
non-concentration dependent genotoxicity that reached the levels of the maximum oil-induced DNA
damage at a very low concentration (44.8 µg/mL) (Figure 1B). In addition, it caused a 2.2-fold DNA
damage compared to the control group at the highest concentration used (448 µg/mL), which was half
the maximum concentration of the oil (920 µg/mL).
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Figure 1. Detection of DNA damage caused by Lippia citriodora oil and citral in Jurkat cells using comet
assay. Jurkat cells (2 × 104) were incubated with Lippia citriodora oil (A) or citral (B) for 20 min at room
temperature. Results are shown as Mean ± S.D. * p < 0.05, ** p < 0.01, *** p < 0.001.
Moreover, we used two conc ntrations of both agen s (esse ti l oil, 92 and 640 µg/mL; citral,
4.48 and 44.8 µg/mL) to assess the protective effect of each agent against H2O2-induced oxidative
damage. Overall, both agents exhibited similar levels of protection only at the highest concentration
used, with the oil providing slightly more protection than citral (2.24-fold vs. 2.7-fold the DNA of
control sample, respectively) (Figure 2A,B).
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Figure 2. Detection of the protective effect of Lippia citriodora oil and citral on H2O2-treated Jurkat cells.
Jurkat cells (2 × 104) were preincubated with Lippia citriodora oil (A) or citral (B) for 20 min before
treatment with H2O2 (6.66 µg/mL) for 20 min at room temperature. Results are shown as mean ± S.D.
# p = 0.013 H2O2 vs. H2O2 and 640 µg/mL essential oil, # p < 0.05 relative to H2O2, *** p < 0.001 relative
to control.
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The oil from Lippia citriodora together with citral have been previously evaluated for their
antigenotoxic effect against ultraviolet radiation-induced DNA damage using the SOS chromosome
test, where they both showed antigenotoxicity [25]. Citral has shown diverse toxicity using different
test systems. For instance, it not did exhibit direct pro-oxidant effect when testing oxygen uptake in
erythrocytes exposed to tert-butyl hydroperoxide (t-BHP) [26], nor did it reduce the viability of rat small
intestine epithelial cells after 24 h of incubation [17]. When using the Salmonella mutagenicity testing,
Gomes-Carneiro et al., demonstrated that citral was toxic at concentrations higher than 600 µg/mL,
whereas it did not demonstrate any such genotoxicity when utilizing the SOS chromotest [27,28].
Moreover, in a similar study, citral was shown to reduce the viability of human lymphocytes over
100 µg/mL using the MTT assay and cause statistically significant DNA damage at even lower
concentrations (>25 µg/mL), in accordance with our results [29].
2.5. Antiproliferative Activity
Increasing concentrations of the essential oil fraction (0.64–920 µg/mL) or citral (0.63–900 µg/mL)
were incubated with different human cancer cell lines (for 72 h) and SRB or XTT assays were
employed to determine cell viability. Overall, it was observed that the oil fraction was most cytotoxic
against the A375 (melanoma) cells (EC50 = 9.1 ± 0.6 µg/mL), an activity eight to ten times higher
compared to the other cell lines tested. In addition, it showed similar viability levels against HepG2
(hepatocellular carcinoma), MCF-7 (breast adenocarcinoma) and Caco2 (colon adenocarcinoma) cells
(EC50 = 74 ± 2.8 µg/mL, 89± 1.4 µg/mL and 71± 2.6 mg/mL, respectively), while it was slightly less
cytotoxic against THP-1 (leukemic monocytes) cells (EC50 = 111 ± 3.6 µg/mL) (Figure 3 and Table 5).
Finally, the oil fraction demonstrated modest cytotoxicity to the lines tested compared with etoposide,
a known chemotherapeutic agent. To our knowledge, there are no published data on the cytotoxicity of
the essential oil of Lippia citriodora against HepG2 and Caco2 cell lines. In a study in 2010, Escobar et al.
showed the effect of Lippia citriodora oil (from Colombian plants) against Vero and THP-1 cells where
the EC50 value for THP-1 was >100 µg/mL, in accordance with our results [30]. There is also one study
describing the cytotoxic activity of Aloysia citriodora oils from different regions of Morocco against
MCF-7 cells after a 48 h incubation, where the EC50 values ranged between 35 and 70 µg/mL, whereas
there was no cytotoxicity observed against PBMCs [31]. In this case, the oils demonstrated higher
activity compared to our oil, which may be attributed to the differences in their composition, as the
Moroccan oils had β-spathulenol, trans-caryophyllene oxide and ar-curcumene as major components.
On the other hand, citral was significantly more potent against all cell lines tested, an observation
which could owe to an antagonistic effect between the components of the essential oil. In general,
MCF-7 cells were the most sensitive ones when subjected to citral (EC50 = 1.3 ± 0.19 µg/mL), followed
by Caco2 and HepG2 cells (EC50 = 3.7 ± 0.21 µg/mL and 7 ± 0.35 µg/mL, respectively) (Figure 4
and Table 5). To this end, another study utilizing citral (obtained commercially) and also tested
against MCF-7 cells showed an EC50 value of 22 µg/mL [32], an effect significantly smaller than
that of our study, which may be attributed to the different cell viability assay used. In another
study, citral has been tested against HepG2 cells after 24 and 48 h of incubation (EC50 = 30.129 and
14.67 µg/mL, respectively), in accordance with our results, where after 72 h the EC50 value was even
lower, suggesting a time-dependent effect [19], while it has also been tested for its cytotoxicity against
a range of human cancer cell lines including breast carcinoma, glioblastoma, malignant melanoma,
and colon carcinoma after a 72 h incubation, exhibiting potent activity [18].
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Figure 4. Antiproliferative activity of citral against a panel of three human cancer cell lines. Cancer cells
were incubated with increasing concentrations of citral for 72 h. Estimation of cell viability was
determin d by the SRB assay. Representat ve figures of at least three experiments.
Table 5. EC50 values of the essential oil of Lippia citriodora and its major component, citral, against
different human cell lines. Etoposide was used as a positive control.
EC50 (µg/mL)
HepG2 Caco2 MCF-7 THP-1 A375
Lippia citriodora oil 74 ± 2.8 71 ± 2.6 89 ± 1.4 111 ± 3.6 9.1 ± 0.6
Citral 7 ± 0.35 3.7 ± 0.21 1.3 ± 0.19 - -
Etoposide 0.60 ± 0.06 7.3 ± 0.63 1.67 ± 0.41 0.45 ± 0.013 -
Data are presented as mean ± SD of at least three independent experiments.
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3. Materials and Methods
3.1. Plant Material
Plant material was purchased by Vioryl S.A. from a local area herbal market (Afidnes, Athens,
Greece) and the species was confirmed by a professional botanist. Plants were small shrubs of almost
60 cm height. They were kept in pots until the first inflorescence appeared and leaves and stems
were collected.
3.2. Chemicals and Reagents
Brain heart infusion (BHI) broth, malt extract agar, and Ringer’s solution were obtained from
LABM (Heywood, UK). Ciproxin was obtained from Oxoid Ltd. (Basingstoke, UK) and amphotericin B
from Mast Group Ltd. (Merseyside, UK). Dulbecco’s Modified Eagle’s Medium (DMEM), DMEM high
glucose, RPMI media, and low melting agarose were purchased from Gibco® (Gaithersburg, MD, USA).
Fetal bovine serum (FBS), trypsin, penicillin/streptomycin, trypan blue 0.5%, and phosphate-buffered
saline (PBS) were purchased from Biosera (Boussens, France). Dimethyl sulfoxide (DMSO) and
propidium iodide were purchased from Biotium (Hayward, CA, USA), while hydrogen peroxide,
ABTS, potassium persulfate, ascorbic acid, sulforhodamine B (SRB), Trizma base, and etoposide
were purchased from Sigma-Aldrich (St. Louis, MO, USA). Trichloroacetic acid (TCA) was obtained
from MP Biomedicals (Santa Ana, CA, USA). Acetic acid and ethanol were purchased from Scharlau
(Barcelona, Spain) and DPPH from Calbiochem® (Darmstadt, Germany).
3.3. Essential Oil Extraction and GC/MS Analysis
The essential oil was obtained by hydrodistillation at VIORYL S.A. facilities (Afidnes, Athens,
Greece) directly after the harvesting period, taking into account the seasonality of the plant. All plants
were harvested during May and June, and no further drying process was used. Chopped leaves
and stems were collected by hand, followed by hydrodistillation with a Dean Stark apparatus.
Plant material was covered with 6 L of distilled water, while the extraction process took place for 8 h at
a temperature of 90–120 ◦C. Isolated essential oil was dried with Na2SO4 and sealed in vials for further
use. Analysis was carried out with a GC-MS (GC: 6890A, Agilent Technologies, Santa Clara, CA,
USA; MSD: 5973, Agilent Technologies, Santa Clara, CA, USA) using a Factor Four VF 1 ms column
(25 m, 0.2 mm i.d., 0.33 µm film thickness, Agilent Technologies, Santa Clara, CA, USA). A volume
of 0.1 µL of essential oil was directly injected and a 1:100 split ratio was applied. Oven temperature
was set at 50 ◦C for 1 min, followed by a temperature gradient of 2.5 ◦C/min to 160 ◦C (for 20 min),
then raised to 250 ◦C at 50 ◦C/min with a final isothermal period of 15 min. Helium was used as the
carrier gas (flow rate 1 mL/min). Injector and transfer line temperatures were set to 200 ◦C and 250 ◦C,
respectively. The mass spectrometer operated in the electron impact mode with the electron energy set
to 70 eV. Identification of the compounds was carried out according to the standard method of Kováts
Indices and comparison of volatiles mass spectra to Willey/NIST 0.5 and in-house created libraries
(VIORYL S.A.).
3.4. Microbial Strains
Salmonella enterica subsp. enterica ser. Enteritidis FMCC B56 PT4 (kindly provided by Prof. Nychas
G.J.E., Agricultural University of Athens, Athens, Greece), Salmonella enterica subsp. enterica ser.
typhimurium DSMZ 554, Listeria monocytogenes NCTC 10527 serotype 4b, Escherichia coli ATCC 25922,
Staphylococcus epidermidis FMCC B-202 C5M6 (kindly provided by Dr. Nisiotou A., Athens Wine
Institute, ELGO-DIMITRA, Athens, Greece) and Staphylococcus aureus ATCC 25923 were grown in BHI
at 37 ◦C for 24 h. Likewise, Pseudomonas fragi 211 (kindly provided by Prof. Nychas G.J.E., Agricultural
University of Athens, Greece) was grown in BHI broth at 25 ◦C for 24 h. Saccharomyces cerevisiae
uvaferm NEM (Lallemand, Montreal, QC, Canada) was grown in YPD broth (yeast extract, 10 g/L;
glucose, 20 g/L; and peptone, 20 g/L) at 28 ◦C for three days. Aspergillus niger 19111 (kindly provided
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by Prof. Nychas G.J.E., Agricultural University of Athens) was grown on malt extract agar for seven
days at 37 ◦C.
3.5. Antimicrobial Assays
The antimicrobial activity of the tested essential oil and determination of minimum inhibitory
concentration (MIC) and non-inhibitory concentration (NIC) based on the Lambert-Pearson model
(LPM) [10,11] were monitored using previously published methodologies [12,33]. In brief, the effect
on the growth, measured by the optical density method, is manifested by a reduction in the area under
the OD/time relative to a control well at any specified time (supplementary material). By calculating
the area using the trapezoidal rule (Equation (1)), the relative amount of growth were obtained using
the ratio of the test area to that of the control, termed the fractional area, fa. Data were fitted to the
LPM using non-linear least squares regression analysis assuming equal variance.
f a = exp
[
−
(
x
P1
)P2]
(1)
where fa is the fractional area, x is the inhibitor concentration (µg/mL), P1 is the concentration at
maximum slope (of a logx vs. fa plot), and P2 is a slope parameter.
MIC was defined as the intercept of the concentration axis to the tangent at the maximum gradient
of the fa/log concentration curve (Equation (2)):
MIC = P1 exp
(
1
P2
)
(2)
NIC was defined as the intercept of the tangent at the maximum gradient of the fa/log
concentration curve to the fa = 1 contour (Equation (3)):
NIC = P1 exp
(
1− e
P2
)
(3)
3.6. Antioxidant Activity
3.6.1. DPPH Assay
The radical scavenging activity of the essential oil and citral was estimated using the free radical
DPPH, as previously described [12]. Increasing concentrations of the essential oil (0.0046–46 mg/mL)
and citral (0.0045–45 mg/mL) were prepared using DMSO as the solvent. Absorbance was measured
at 517 nm using an ELISA plate reader (EnSpire Multimode Plate Reader, Perkin Elmer, Waltham, MA,
USA). All determinations were performed in triplicates. The % inhibition of the DPPH radical for each
concentration was determined by making use of the following formula: % DPPH radical scavenging
activity = [(ODcontrol − ODsample)/ODcontrol)] × 100.
3.6.2. ABTS Assay
The ABTS de-coloration assay was performed as previously described [12,34]. The % inhibition
of the ABTS radical for each concentration is expressed in two ways; First, by making use of the
following formula: % ABTS radical scavenging activity = [(ODcontrol − ODsample)/ODcontrol)] × 100.
Next, a standard curve based on the percentage of ABTS radical scavenging activity of known
concentrations of ascorbic acid expressed in µM was prepared and the concentrations of the samples
were calculated using linear regression analysis and the results were also expressed as micromoles
ascorbic acid equivalent per gram of essential oil (µmolesEA/g), by making use of the following
formula: C = (cxD)/Ci. C, concentration of antioxidant compounds in µmolesEA/g; c, concentration
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of sample read (in micromoles per liter); D, dilution factor; Ci, concentration of stock solution (in grams
per liter).
3.7. Cell Lines and Cell Cultures
The human cancer cell lines Caco2 (colorectal adenocarcinoma), HepG2 (hepatocellular
carcinoma), MCF-7 (breast adenocarcinoma), THP-1 (leukemic monocytes), Jurkat (acute T cell
leukemia), and A375 (malignant melanoma) were obtained from the American type culture collection
(Rockville, MD, USA). HepG2 and MCF-7 cells were grown and maintained in DMEM, A375
cells in DMEM high glucose (4500 mg/L), whereas the medium RMPI was used for the Caco2,
Jurkat, and THP-1 cell lines. All media were supplemented with 10% FBS, penicillin (100 U/mL),
and streptomycin (100 µg/mL) and were incubated at 37 ◦C in a humidified atmosphere of 95% O2
and 5% CO2. Stock cultures were passaged at 2- to 3-day intervals. Cells were seeded at a density of
5.0 × 103 cells per well in 96-well plates for the SRB assay. THP-1 cells were seeded at a density of
2.0 × 103 cells per well in round bottom 96-well plates for the XTT assay.
3.8. Single Cell Gel Electrophoresis Assay (Comet Assay)
The alkaline version of the single-cell gel electrophoresis assay was used to evaluate DNA damage
of the essential oil and citral, as well as their protective effect from H2O2-induced oxidative damage.
Briefly, Jurkat cells (2 × 104 cells/sample in PBS) were maintained on ice. Cells were treated with
increasing concentrations of the essential oil or citral alone for 20 min or followed by treatment with
H2O2 (6.66 µg/mL) for another 20 min at room temperature. Comet assay was performed as previously
described [35]. The slides were processed for evaluation on a Zeiss Axio Scope.A1 fluorescence
microscope (Oberkochen, Germany). The overall DNA damage was calculated in arbitrary units.
Results were expressed as % DNA damage relative to control.
3.9. Cell Viability Assays
3.9.1. SRB Assay
The viability of the human cancer cells HepG2, Caco2, MCF-7, and A375 after treatment
with the essential oil and its major component was determined using the SRB assay as previously
described [12]. Cells were plated in 96-well plates and treated with increasing concentrations of the oil
(0.64–920 µg/mL) and citral (0.63–900 µg/mL) (dissolved in DMSO, 1:1 v/v) for 72 h.
3.9.2. XTT Assay
The viability of THP-1 cells was determined by the XTT assay as previously described [12,36].
Cells were seeded in a 96-well-plate and following an overnight incubation they were treated with
increasing concentrations of the oil (0.64–920 µg/mL) or citral (0.63–900 µg/mL) (dissolved in DMSO,
1:1 v/v) for 72 h. At the end of the incubation, the XTT solution was added, and plates were incubated
further for 4 h before reading the absorbance at 450 nm by a microplate reader (EnSpire Multimode
Plate Reader, Perkin Elmer, Waltham, MA, USA).
3.10. Data Analysis
All experiments were performed at least in triplicate. For MIC and NIC determination,
each experiment was performed at least 4 times, and standard deviation was calculated by Fig.P
software (Fig.P Software Incorporated, Hamilton, ON, Canada). Significance was established at p < 0.05
and the results were analyzed for statistical significance with analysis of variance (ANOVA). Duncan’s
multiple range test was used to determine significant differences among results using Statistica
v.10.0. The IC50 (inhibition concentration) and EC50 (efficient concentration) values were calculated
as previously described [12]. For comet assay, statistical differences between groups were evaluated
by ANOVA followed by Dunnett’s or Tukey’s test. A level of p < 0.05 was considered statistically
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significant. All statistical analyses were performed using GraphPad Prism 5 (GraphPad Software,
San Diego, CA, USA).
4. Conclusions
Citral is the major component of the essential oil of Lippia citriodora (obtained from Greek plants)
and exhibited significant antimicrobial activity against all microbes tested in contrast to the oil fraction
which was inactive against the gram negative bacteria. Our results also suggest that both the oil
fraction and citral exhibit potent antiproliferative activities in vitro. More specifically, citral was
more cytotoxic against all cancer cell lines utilized in the scope of this study while the oil fraction
exhibited lower genotoxicity. Although both the oil and citral proved weak direct antioxidants
as assessed by biochemical in vitro assays, they, nevertheless, exhibited antioxidant capacity in a
cellular system demonstrated as a significant reduction of the H2O2-induced oxidative damage.
Many of these properties are reported here for the first time, thus setting the basis for further
investigations regarding the active components of the oil and the molecular mechanisms(s) underlying
their mode of action. This is of utmost importance as the demand in identifying natural products with
well-described biological properties for potential neutraceutical and pharmaceutical applications is
constantly increasing.
Supplementary Materials: Supplementary materials are available online.
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